Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70


CXCR4 suppression attenuates EGFRvIII-mediated invasion and induces p38 MAPK-dependent protein trafficking and degradation of EGFRvIII in breast cancer cells.

Rahimi M, Toth TA, Tang CK.

Cancer Lett. 2011 Jul 1;306(1):43-51. doi: 10.1016/j.canlet.2011.02.024. Epub 2011 Mar 30.


EGFR variant-mediated invasion by enhanced CXCR4 expression through transcriptional and post-translational mechanisms.

Rahimi M, George J, Tang C.

Int J Cancer. 2010 Apr 15;126(8):1850-60. doi: 10.1002/ijc.24964.


Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway.

Mao L, Yuan L, Slakey LM, Jones FE, Burow ME, Hill SM.

Breast Cancer Res. 2010;12(6):R107. doi: 10.1186/bcr2794. Epub 2010 Dec 17.


A novel biphenyl urea derivate inhibits the invasion of breast cancer through the modulation of CXCR4.

Zhan Y, Zhang H, Li J, Zhang Y, Zhang J, He L.

J Cell Mol Med. 2015 Jul;19(7):1614-23. doi: 10.1111/jcmm.12536. Epub 2015 Mar 8.


Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.

Tang CK, Gong XQ, Moscatello DK, Wong AJ, Lippman ME.

Cancer Res. 2000 Jun 1;60(11):3081-7.


NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4.

Helbig G, Christopherson KW 2nd, Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD, Broxmeyer HE, Nakshatri H.

J Biol Chem. 2003 Jun 13;278(24):21631-8. Epub 2003 Apr 9.


[Chemokine receptor CXCR4 gene silencing with shRNA inhibits breast cancer metastasis to the lung in nude mice].

Zhang MX, Han N, Yu SY, Leng Y.

Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):325-9. Chinese.


ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer.

Appaiah H, Bhat-Nakshatri P, Mehta R, Thorat M, Badve S, Nakshatri H.

Cancer Biol Ther. 2010 Sep 15;10(6):600-14. Epub 2010 Sep 4.


RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.

Feng Y, Hu J, Ma J, Feng K, Zhang X, Yang S, Wang W, Zhang J, Zhang Y.

Eur J Cancer. 2011 Oct;47(15):2353-63. doi: 10.1016/j.ejca.2011.05.006. Epub 2011 Jun 15.


TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells.

Howlin J, Rosenkvist J, Andersson T.

Breast Cancer Res. 2008;10(2):R36. doi: 10.1186/bcr2087. Epub 2008 Apr 24.


p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion.

Hong B, Li H, Zhang M, Xu J, Lu Y, Zheng Y, Qian J, Chang JT, Yang J, Yi Q.

Int J Cancer. 2015 Jan 1;136(1):34-43. doi: 10.1002/ijc.28958. Epub 2014 May 16.


Gene silencing for epidermal growth factor receptor variant III induces cell-specific cytotoxicity.

Yamoutpour F, Bodempudi V, Park SE, Pan W, Mauzy MJ, Kratzke RA, Dudek A, Potter DA, Woo RA, O'Rourke DM, Tindall DJ, Farassati F.

Mol Cancer Ther. 2008 Nov;7(11):3586-97. doi: 10.1158/1535-7163.MCT-08-0653.


Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4.

Cronin PA, Wang JH, Redmond HP.

BMC Cancer. 2010 May 21;10:225. doi: 10.1186/1471-2407-10-225.


Procollagen I COOH-terminal fragment induces VEGF-A and CXCR4 expression in breast carcinoma cells.

Palmieri D, Astigiano S, Barbieri O, Ferrari N, Marchisio S, Ulivi V, Volta C, Manduca P.

Exp Cell Res. 2008 Jul 1;314(11-12):2289-98. doi: 10.1016/j.yexcr.2008.04.016. Epub 2008 May 10.


Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.

Mehta SA, Christopherson KW, Bhat-Nakshatri P, Goulet RJ Jr, Broxmeyer HE, Kopelovich L, Nakshatri H.

Oncogene. 2007 May 17;26(23):3329-37. Epub 2006 Nov 27.


Norepinephrine attenuates CXCR4 expression and the corresponding invasion of MDA-MB-231 breast cancer cells via β2-adrenergic receptors.

Wang LP, Jin J, Lv FF, Cao J, Zhang J, Wang BY, Shao ZM, Hu XC, Wang ZH.

Eur Rev Med Pharmacol Sci. 2015 Apr;19(7):1170-81.

Supplemental Content

Support Center